Agilon Health, Inc.
AGLNYSEHealthcare● Active
$96.61
+$1.28(+1.34%)
Market Cap$1.6B
P/E Ratio—
52W High$101.7603
52W Low$7.48
Agilon Health, Inc.（AGL）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AGL · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.29B | $0.41B | $0.50B | $0.88B | $1.05B |
| Net Receivables | $0.67B | $1.02B | $0.94B | $0.49B | $0.29B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $1.10B | $1.46B | $1.48B | $1.45B | $1.37B |
| PP&E Net | $0.03B | $0.04B | $0.04B | $0.03B | $0.02B |
| Goodwill | $0.00B | $0.02B | $0.02B | $0.00B | $0.00B |
| Intangible Assets | $0.07B | $0.07B | $0.06B | $0.02B | $0.10B |
| Total Assets | $1.27B | $1.73B | $1.74B | $1.70B | $1.59B |
| Liabilities | |||||
| Short-Term Debt | $0.02B | $0.00B | $0.01B | $0.01B | $0.01B |
| Accounts Payable | $1.06B | $1.15B | $0.97B | $0.48B | $0.35B |
| Total Current Liabilities | $1.08B | $1.15B | $0.98B | $0.54B | $0.36B |
| Long-Term Debt | $0.02B | $0.03B | $0.03B | $0.04B | $0.04B |
| Total Liabilities | $1.14B | $1.26B | $1.08B | $0.66B | $0.49B |
| Stockholders Equity | |||||
| Retained Earnings | ($1.98B) | ($1.59B) | ($1.33B) | ($1.06B) | ($0.96B) |
| Total Stockholders Equity | $0.13B | $0.47B | $0.66B | $1.04B | $1.09B |
| Total Liab & Equity(computed) | $1.27B | $1.73B | $1.74B | $1.70B | $1.59B |
| Debt Summary | |||||
| Total Debt | $0.04B | $0.04B | $0.05B | $0.05B | $0.06B |
| Net Debt | ($0.14B) | ($0.15B) | ($0.06B) | ($0.41B) | ($1.00B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Agilon Health, Inc.
关于Agilon Health, Inc.（AGL）资产负债表
Agilon Health, Inc.总资产$1.27B，现金及短期投资$0.29B，总负债$1.14B，总债务$0.04B，股东权益$0.13B。
常见问题
AGL · 4 问Agilon Health, Inc.总债务$0.04B，净债务($0.14B)。
AGL total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10